As much of the world awaits vaccines for COVID-19, discussions on how pathogens should be shared continue to […]
Category Archive: INDUSTRY
ROAD AHEAD FOR GREATER DELIBERATION IN 2021: TRIPS WAIVER PROPOSAL AT WTO The General Council at WTO, the organization’s highest […]
An informal meeting was convened at the TRIPS Council today (December 3) to discuss the TRIPS waiver proposal. […]
THE NEED FOR REGULATORY COHERENCE: LESSONS FROM REMDESIVIR The story of Gilead’s drug remdesivir, one of the earliest […]
The World Health Assembly draws all member states of World Health Organization to discuss health challenges, review actions, […]
Sridhar Venkatapuram, is an Associate Professor at the Global Health Institute, King’s College London. He has spearheaded the Independent […]
A SHORT BLOG: Questions are beginning to emerge as to why WHO proceeded to give a prequalification listing to […]
Given the scientific, economic, political, commercial and moral compulsions around vaccines for the pandemic, the adverse event in […]
Q&A with Benn McGrady, Technical Officer (Legal), Public Health Law and Policies, Health Promotion (HPR) at World Health […]